BioInfra Life Science Inc. (XKON:266470)
South Korea · Delayed Price · Currency is KRW 101.00
+2.00 (2.02%)
At close: Oct 2, 2026
BioInfra Life Science Market Cap
BioInfra Life Science has a market cap or net worth of 2.19 billion as of October 2, 2026. Its market cap has decreased by -44.81% in one year.
Market Cap
2.19B
Enterprise Value
n/a
Revenue
1.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
101.00
ChartMarket Cap Chart
Since July 22, 2020, BioInfra Life Science's market cap has decreased from 57.13B to 2.19B, a decrease of -96.17%. That is a compound annual growth rate of -40.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 2.19B | -63.27% |
| Dec 30, 2025 | 5.96B | -33.89% |
| Dec 30, 2024 | 9.01B | 75.26% |
| Dec 28, 2023 | 5.14B | -65.89% |
| Dec 29, 2022 | 15.08B | -60.07% |
| Dec 30, 2021 | 37.76B | -10.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RecensMedical | 96.36B |
| Corentec | 69.05B |
| DENTIS CO.,Ltd | 41.18B |
| Finemedix | 33.94B |
| Sanigen Co. | 28.78B |
| Genolution | 26.54B |
| TASCOM | 22.85B |
| Alpha AI | 10.45B |